Dezembro 2018 vol. 4 num. 1 - VI Congresso Médico Universitário São Camilo

Oral - Open Access.

Idioma principal | Segundo idioma

TRATAMENTO NÃO FARMACOLÓGICO PARA SÍNDROME DOS OVÁRIOS POLICÍSTICOS

TRATAMENTO NÃO FARMACOLÓGICO PARA SÍNDROME DOS OVÁRIOS POLICÍSTICOS

Maia, L. O.; Furquim, I.; Pereira, M. M.; Vilarino, F.;

Oral:

A síndrome dos ovários policísticos (SOP) é um distúrbio endócrino metabólico. Suas manifestações clínicas podem incluir irregularidades menstruais, sinais de hiperandrogenismo e obesidade. Contraceptivos orais e agentes sensibilizadores de insulina são a primeira linha de tratamento, entretanto, devido os efeitos colaterais, desencadeiam, baixa adesão frequentemente. Nesse sentido, surgem novas terapias alternativas no tratamento da SOP, que pretendem ter resultados iguais ou melhores em comparação às terapias tradicionais utilizadas.

Oral:

A síndrome dos ovários policísticos (SOP) é um distúrbio endócrino metabólico. Suas manifestações clínicas podem incluir irregularidades menstruais, sinais de hiperandrogenismo e obesidade. Contraceptivos orais e agentes sensibilizadores de insulina são a primeira linha de tratamento, entretanto, devido os efeitos colaterais, desencadeiam, baixa adesão frequentemente. Nesse sentido, surgem novas terapias alternativas no tratamento da SOP, que pretendem ter resultados iguais ou melhores em comparação às terapias tradicionais utilizadas.

Palavras-chave: polycystic ovary syndrome, PCOS,

Palavras-chave: polycystic ovary syndrome, PCOS,

DOI: 10.5151/comusc2018-07

Referências bibliográficas
  • [1] Assunção M, Calvo RM, San Millán JL , et al. Um estudo prospectivo da prevalência da síndrome dos ovários policísticos em mulheres caucasianas não selecionadas da Espanha . J Clin Endocrinol Metab 2000 ; 85 : 2434 - 8 . http://dx.doi.org/10.1210/jcem.85.7.6682
  • [2] Março de WA ,Moore VM ,Willson KJ , et al. A prevalência da síndrome dos ovários policísticos em uma amostra da comunidade avaliada sob critérios diagnósticos contrastantes . Hum Reprod 2010 ; 25 : 544 - 51 . doi: 10.1093 / humrep / dep399
  • [3] Balen AH, Laven JSE, Dewailly D. Ultrasound assessment of the polycystic ovary: international consensus definition. Hum Reprod 2003; 9(6):505-14.
  • [4] The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks to polycystic ovary syndrome (PCOS). Hum Reprod 2004; 19(1):41-7.
  • [5] Jin C, Wei L, Zhao J, Wu Z. [Efficacy comparison between electroacupuncture and dyne-35 in treatment of polycystic ovary syndrome]. Zhongguo Zhen Jiu = Chinese Acupuncture & Moxibustion [serial on the Internet]. (2014, Dec), [cited July 24, 2018]; 34(12): 1174-1178.
  • [6] Kort D, Lobo R. Preliminary evidence that cinnamon improves menstrual cyclicity in women with polycystic ovary syndrome: a randomized controlled trial. American Journal Of Obstetrics And Gynecology [serial on the Internet]. (2014, Nov), [cited July 24, 2018]; 211(5): 487.e1-
  • [7] Jang M, Lee M, Lee J, Bae C, Kim S, Cho I, et al. Oriental medicine Kyung-Ok-Ko prevents and alleviates dehydroepiandrosterone-induced polycystic ovarian syndrome in rats. Plos One [serial on the Internet]. (2014, Feb 10), [cited July 24, 2018]; 9(2): e87623.
  • [8] Hong Y, Wu F. [Effect of Bushen Huatan Recipe on the Akt signal pathway in polycystic ovarian syndrome model rats with insulin resistance: an experimental research]. Zhongguo Zhong Xi Yi Jie He Za Zhi Zhongguo Zhongxiyi Jiehe Zazhi = Chinese Journal Of Integrated Traditional And Western Medicine [serial on the Internet]. (2014, Feb), [cited July 24, 2018]; 34(2): 230-234.
  • [9] Huang Y, Li W, Wang C, Wu X, Zheng J. Cryptotanshinone reverses ovarian insulin resistance in mice through activation of insulin signaling and the regulation of glucose transporters and hormone synthesizing enzymes. Fertility And Sterility [serial on the Internet]. (2014, Aug), [cited July 24, 2018]; 102(2): 589-596.e4. Available from: MEDLINE Complete.
  • [10] Lu C, Zhao X, Li Y, Li Y, Yuan C, Xu G, et al. Serum metabolomics study of Traditional Chinese medicine formula intervention to polycystic ovary syndrome. Journal Of Pharmaceutical And Biomedical Analysis [serial on the Internet]. (2016, Feb 20), [cited July 24, 2018]; 120127-133
  • [11] Swaroop A, Jaipuriar A, Gupta S, Bagchi M, Kumar P, Bagchi D, et al. Efficacy of a Novel Fenugreek Seed Extract (Trigonella foenum-graecum, Furocyst) in Polycystic Ovary Syndrome (PCOS). International Journal Of Medical Sciences [serial on the Internet]. (2015, Oct 3), [cited July 24, 2018]; 12(10): 825-831.
  • [12] Wang L, Wang X, Yu X, Xu W. Potent therapeutic effects of shouwu jiangqi decoction on polycystic ovary syndrome with insulin resistance in rats. Chinese Journal Of Integrative Medicine [serial on the Internet]. (2016, Feb), [cited July 24, 2018]; 22(2): 116-123.
  • [13] Jiang D, Zhang Y, Wu X, Wu S. [Infertility in polycystic ovary syndrome treated with acupuncture and clomiphene: a randomized controlled trial]. Zhongguo Zhen Jiu = Chinese Acupuncture & Moxibustion [serial on the Internet]. (2015, Feb), [cited July 24, 2018]; 35(2): 114-118.
  • [14] Lai L, Flower A, Prescott P, Wing T, Moore M, Lewith G. Standardised versus individualised multiherb Chinese herbal medicine for oligomenorrhoea and amenorrhoea in polycystic ovary syndrome: a randomised feasibility and pilot study in the UK. BMJ Open [serial on the Internet]. (2017, Feb 3), [cited July 24, 2018]; 7(2): e011709.
  • [15] Fauser BC, Pache TD, Lamberts SW, Hop WC, de Jong FH, Dahl KD. Serum bioactive and immunoreactive LH and FSH levels in women with cycle abnormalities, with or without PCOD. J Clin Endocrinol Metab 1991;73:811–7.
  • [16] Taylor AE, McCourt B, Martin K, Anderson EJ, Adams J, Schoebfeld D, et al. Determinants of abnormal gonadotropin secretion in clinically dened women with PCOS. J Clin Endocrinol Metab 1997;82:2248– 56.
  • [17] Azziz R, Marin C, Hoq L, Badamgarav E, Song P. Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span. The Journal Of Clinical Endocrinology And Metabolism [serial on the Internet]. (2005, Aug), [cited July 25, 2018]; 90(8): 4650-4658.
  • [18] Teixeira Filho FL, Baracat EC, Lee TH, Suh CS, Matsui M, Chang RJ, Shimasaki S, Erickson GF. Aberrant expression of growth differentiation factor-9 in oocytes of women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2002;87(3):1337-44.
  • [19] Giudice LC. Endometrium in PCOS: Implantation and predisposition to endocrine CA. Best Pract Res Clin Endocrinol Metab. 2006;20(2):235-44
  • [20] Barber TM, Wass JA, McCarthy MI, Franks S. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome. Clin Endocrinol (Oxf). 2007;66(4):513-7.
  • [21] de Paula Martins W, Santana LF, Nastri CO, Ferriani FA, de Sa MF, Dos Reis RM. Agreement among insulin sensitivity indexes on the diagnosis of insulin resistance in polycystic ovary syndrome and ovulatory women. Eur J Obstet Gynecol Reprod Biol. 2007 Jan 4; [Epub ahead of print]
  • [22] Azziz R, Hincapie LA, Knochenhauer ES, Dewailly D, Fox L, Boots LR. Screening for 21-hydroxylase decient non-classic adrenal hyperplasia among hyperandrogenic women: a prospective study. Fertil Steril 1999;72:915–25.
  • [23] ESHRE Capri Workshop Group. Anovulatory infertility. Hum Reprod 1995;10:1549–53
  • [24] Rowe PJ, Comhaire FH, Hargreave TB. Female partner. In: World Health Organization manual for the standardized investigation and diagnosis of the infertile couple. Cambridge: Cambridge University Press, 2000:40–67. 18. Van Santbrink EJ, Hop WC, Fauser BC. Classication of normogonadotropin infertility: polycystic ovaries diagnosed by ultrasound versus endocrine characteristics of PCOS. Fertil Steril 1997;67:452–8.
  • [25] [I Brazilian guidelines on diagnosis and treatment of metabolic syndrome]. Arquivos Brasileiros De Cardiologia [serial on the Internet]. (2005, Apr), [cited July 26, 2018]; 84 Suppl 11-28.
  • [26] CHEN, B. Y. Acupuncture normalizes dysfunction of hypothalamic-pituitary-ovarian axis. Acupuncture and Electro-Therapeutics, v. 22, p. 97-108, 1997.
Como citar:

Maia, L. O.; Furquim, I.; Pereira, M. M.; Vilarino, F.; "TRATAMENTO NÃO FARMACOLÓGICO PARA SÍNDROME DOS OVÁRIOS POLICÍSTICOS", p. 78-91 . In: Centro Universitário São Camilo. São Paulo: Blucher, 2018.
ISSN 2357-7282, DOI 10.5151/comusc2018-07

últimos 30 dias | último ano | desde a publicação


downloads


visualizações


indexações